Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
COLIBRI: Levonorgestrel vs Copper IUD Menstrual Bleeding Profile
NCT02957292Phase 4Completed
- Sponsor
- Hospital de la Santa Creu i Sant Pau Research Institute
- Start
- Jun 2016
- Primary completion
- Sep 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, single-blind trial of avatrombopag in contraception (2 arms), sponsored by Hospital de la Santa Creu i Sant Pau Research Institute. Primary endpoints: Number of menstrual bleeding days at 90 days and Amount of Menstrual bleeding at 90 days. Started Jun 2016; status: completed.
02
Drugs
avatrombopag
03
Conditions
contraception
Beyond the preview
Go deeper on NCT02957292.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02957292.